HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults

This study is ongoing, but not recruiting participants.

Study NCT00013572 Information provided by NIH AIDS Clinical Trials Information Service

First Received: March 21, 2001 Last Updated: June 23, 2005 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

No publications provided by NIH AIDS Clinical Trials Information Service

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Eller MA, Slike BM, Cox JH, Lesho E, Wang Z, Currier JR, Darden JM, Polonis VR, Vahey MT, Peel S, Robb ML, Michael NL, Marovich MA. A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells. PLoS One. 2011;6(9):e24254. Epub 2011 Sep 16.